Dr. Jay Heinecke, MD, has been awarded an NIH/NHLBI R01 for his project entitled “Quantitative Assessment of HDL Function”. The goal of the research is to identify proteins that alter HDL’s function and are selectively enriched or depleted in subjects at risk for CVD.  The long-term goal is to understand the factors that impair HDL’s ability to remove cholesterol and inhibit macrophage inflammation, which may have important implications for HDL therapeutics. Dr. Heinecke is a professor of medicine and a member of the Molecular and Cellular Biology Graduate Program.  He holds the Karasinski Chair in Metabolic Research and is director of the DOM Mass Spectrometry Resource.